Please login to the form below

Not currently logged in
Email:
Password:

rights

This page shows the latest rights news and features for those working in and with pharma, biotech and healthcare.

FDA adcomm split on Sanofi’s type 1 diabetes drug

FDA adcomm split on Sanofi’s type 1 diabetes drug

Sanofi licensed rights to sotagliflozin from Lexicon in 2015 for $300m upfront and up to $1.4bn in development, regulatory and sales milestone payments plus double-digit royalties.

Latest news

More from news
Approximately 2 fully matching, plus 2,200 partially matching documents found.

Latest Intelligence

  • Escaping the spin cycle of sub-optimal launch Escaping the spin cycle of sub-optimal launch

    Get the fundamentals right. The fundamentals of launch, says Ed Corbett, are simple. ... to can ensure you make the right decisions,” says Jeremy Poland, Senior Launch Excellence Consultant, Blue Latitude Health.

  • Relearning launch: Four key dynamics for pharma launches in 2019 Relearning launch: Four key dynamics for pharma launches in 2019

    They create their own responsive and right-sized regional teams. The first wave of change was giving regional sales mangers operational control of resources (not just sales accountability).

  • AstraZeneca’s oncology renaissance AstraZeneca’s oncology renaissance

    So how did AstraZeneca achieve this turnaround? In 2010 Mene Pangalos introduced a ‘5R framework’ for R&D: right target, right patient, right tissue, right safety, right commercial potential.

  • Right intervention, right tool

    Is VR the best solution – the right tool for the job – or can we achieve the same goals and better experiences with alternative, more accessible solutions? ... this is the right tool for the tasks we are trying to accomplish.

  • New models of NHS care – new models of pharma response? New models of NHS care – new models of pharma response?

    Instead of being highly trained sales people, they need to be highly efficient facilitators, helping HCPs to get patients early access to the right medications at the right time.

More from intelligence
Approximately 0 fully matching, plus 439 partially matching documents found.

Latest appointments

  • Weekly industry appointments Weekly industry appointments

    Gelesis adds to company. Biotech Gelesis has bolstered its offering with the addition of Harry Leider (pictured top right), former chief medical officer and group vice president of pharmacy company Walgreens. ... Also joining the company is Boehringer

  • Weekly comms appointments Weekly comms appointments

    Sarah Winterbottom joins ROAD. Independent healthcare communications specialist ROAD has appointed Sarah Winterbottom (pictured right) as senior director. ... W2O appoints Ujwal Pyati. W2O, a network of analytics-driven, digital marketing communications

  • Novartis changes executive committee Novartis changes executive committee

    Narasimhan, said: “Robert’s deep understanding of business services coupled with his strong financial and commercial acumen make him the right person to lead NBS in the next stage of its

  • Building trust in our industry Building trust in our industry

    in this industry to do the right thing). ... The percentage of people who trust the pharmaceutical industry to do the right thing has fluctuated only slightly in recent years and in 2018 was only 54.

  • Gamida Cell strengthens leadership team Gamida Cell strengthens leadership team

    Hamermesh (pictured right), who joins from Locust Walk Partners where he served as senior vice president, will lead the business operations and corporate development strategies for the company.

More from appointments
Approximately 0 fully matching, plus 233 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 391 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Consulting at McCann Health

We are the strategic consultancy of McCann Health. We combine fresh and creative thinking with scientific and strategic depth...

Latest intelligence

Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....

Infographics